Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | NUVL | APLS | ||
| Company | Crispr Therapeutics Ag | Nuvalent Inc Cl A | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 53.98 | 75.53 | 36.20 | ||
| High | 53.98 | 75.56 | 36.34 | ||
| Low | 52.52 | 71.34 | 34.69 | ||
| Last | 53.12 | 73.00 | 34.98 | ||
| Change | -0.83 | -2.51 | -1.31 | ||
| % Change | -1.55% | -3.32% | -3.61% | ||
| Volume | 1,058,900 | 312,800 | 1,763,000 | ||
| 20-Day Average Volume | 1,424,470 | 441,395 | 1,393,860 | ||
| Previous Close | 53.95 | 75.51 | 36.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.85 | 77.73 | 40.14 | ||
| 20-Day Raw Stochastic | 3.87% | 32.38% | 3.20% | ||
| 20-Day Relative Strength | 40.66% | 46.94% | 34.49% | ||
| Weighted Alpha | -20.15 | +44.63 | -41.65 | ||
| Today's Opinion | 72% Sell | 24% Buy | 100% Sell | ||
| Previous Opinion | 72% Sell | 56% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 56% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.07% since 06/25/24 | -9.17% since 06/25/24 | -13.42% since 06/25/24 | ||
| Low | 52.52 on 07/02/24 | 71.34 on 07/02/24 | 34.69 on 07/02/24 | ||
| High | 57.98 on 06/27/24 | 79.99 on 06/26/24 | 41.61 on 06/27/24 | ||
| 1-Month | |||||
| %Chg | -1.16% since 05/31/24 | +11.25% since 05/31/24 | -10.88% since 05/31/24 | ||
| Low | 52.52 on 07/02/24 | 65.10 on 06/03/24 | 34.69 on 07/02/24 | ||
| High | 67.88 on 06/13/24 | 83.35 on 06/06/24 | 43.76 on 06/12/24 | ||
| 3-Month | |||||
| %Chg | -18.32% since 04/02/24 | -0.57% since 04/02/24 | -37.20% since 04/02/24 | ||
| Low | 51.02 on 05/10/24 | 61.79 on 04/19/24 | 34.69 on 07/02/24 | ||
| High | 67.88 on 06/13/24 | 83.35 on 06/06/24 | 58.12 on 04/04/24 | ||
| 6-Month | |||||
| %Chg | -19.60% since 01/02/24 | -4.07% since 01/02/24 | -42.91% since 01/02/24 | ||
| Low | 51.02 on 05/10/24 | 61.79 on 04/19/24 | 34.69 on 07/02/24 | ||
| High | 91.10 on 02/22/24 | 89.39 on 03/13/24 | 73.80 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,581,326 | 4,874,623 | 4,404,372 | ||
| Shares Outstanding, K | 84,918 | 64,556 | 121,366 | ||
| Annual Sales | 371,210,000 | 0 | 396,590,000 | ||
| Annual Net Income | -153,610,000 | -126,220,000 | -528,630,000 | ||
| Last Quarter Sales | 500,000 | 0 | 172,330,000 | ||
| Last Quarter Net Income | -116,590,000 | -44,480,000 | -66,420,000 | ||
| 60-Month Beta | 1.70 | 1.28 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.43 on 05/08/24 | -0.69 on 05/09/24 | -0.54 on 05/07/24 | ||
| Latest Earnings Date | 08/05/24 | 08/08/24 | 07/29/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||